Enveric Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Enveric Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2023.
  • Enveric Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $9.61K, a 92.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $9.61K -$111K -92.1% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $37K -$114K -75.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $63.8K -$112K -63.8% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $88.8K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $121K Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $151K Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $176K Dec 31, 2021 10-K/A 2023-06-09
Q3 2020 $875K +$559K +177% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $907K +$563K +164% Jun 30, 2020 10-Q 2020-08-14
Q4 2019 $286K -$85.6K -23% Dec 31, 2019 10-Q 2020-11-16
Q3 2019 $315K Sep 30, 2019 10-K/A 2020-08-12
Q2 2019 $344K Jun 30, 2019 10-K/A 2020-08-12
Q4 2018 $372K Jan 2, 2019 10-K/A 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.